X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (49957) 49957
Newsletter (3543) 3543
Newspaper Article (2025) 2025
Magazine Article (133) 133
Book / eBook (97) 97
Book Chapter (48) 48
Publication (28) 28
Dissertation (22) 22
Web Resource (19) 19
Conference Proceeding (17) 17
Book Review (7) 7
Government Document (7) 7
Journal / eJournal (2) 2
Paper (2) 2
Trade Publication Article (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45404) 45404
male (40436) 40436
prostate cancer (27573) 27573
aged (21322) 21322
middle aged (21235) 21235
cancer (18440) 18440
prostatic neoplasms - surgery (17994) 17994
oncology (16805) 16805
prostatic neoplasms - pathology (15437) 15437
urology & nephrology (12826) 12826
prostatectomy (10005) 10005
research (9815) 9815
surgery (8756) 8756
prostate (8401) 8401
care and treatment (8380) 8380
female (8227) 8227
adult (7584) 7584
prognosis (7385) 7385
radical prostatectomy (7063) 7063
aged, 80 and over (6711) 6711
prostate-cancer (6403) 6403
treatment outcome (6099) 6099
metastasis (6092) 6092
prostate-specific antigen - blood (5909) 5909
neoplasm staging (5690) 5690
health aspects (5417) 5417
urology (5354) 5354
retrospective studies (5345) 5345
prostatectomy - methods (5311) 5311
analysis (5260) 5260
carcinoma (5217) 5217
risk factors (5129) 5129
tumors (5106) 5106
oncology, experimental (5063) 5063
radiotherapy (4979) 4979
prostatic neoplasms - diagnosis (4771) 4771
men (4608) 4608
animals (4588) 4588
prostatic neoplasms - radiotherapy (4568) 4568
prostatic neoplasms - therapy (4518) 4518
diagnosis (4465) 4465
biopsy (4062) 4062
follow-up studies (3990) 3990
prostatic neoplasms - drug therapy (3973) 3973
prostatic neoplasms - blood (3953) 3953
prostatic neoplasms (3784) 3784
cell line, tumor (3754) 3754
expression (3711) 3711
survival (3646) 3646
prostatic neoplasms - mortality (3542) 3542
prostate - pathology (3485) 3485
risk (3427) 3427
medicine & public health (3249) 3249
cancer therapies (3230) 3230
patients (3190) 3190
prostate-specific antigen (3110) 3110
radiology, nuclear medicine & medical imaging (3097) 3097
breast-cancer (3071) 3071
prostatic neoplasms - metabolism (3009) 3009
pathology (2885) 2885
development and progression (2828) 2828
time factors (2823) 2823
immunohistochemistry (2817) 2817
mortality (2816) 2816
prostatic neoplasms - genetics (2788) 2788
gene expression (2687) 2687
therapy (2677) 2677
chemotherapy (2635) 2635
prospective studies (2634) 2634
mice (2619) 2619
medicine (2598) 2598
breast cancer (2587) 2587
apoptosis (2570) 2570
quality of life (2566) 2566
progression (2561) 2561
adenocarcinoma (2560) 2560
disease progression (2532) 2532
adenocarcinoma - surgery (2478) 2478
genetic aspects (2435) 2435
adenocarcinoma - pathology (2401) 2401
medical research (2365) 2365
disease-free survival (2281) 2281
neoplasm grading (2278) 2278
research article (2273) 2273
prostatectomy - adverse effects (2267) 2267
radiation therapy (2254) 2254
proteins (2240) 2240
abridged index medicus (2232) 2232
antigen (2232) 2232
studies (2211) 2211
quality-of-life (2134) 2134
outcomes (2117) 2117
radiation-therapy (2096) 2096
magnetic resonance imaging (2075) 2075
gene expression regulation, neoplastic (2050) 2050
cancer patients (2012) 2012
survival rate (1998) 1998
metastases (1988) 1988
hematology, oncology and palliative medicine (1979) 1979
predictive value of tests (1977) 1977
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (31) 31
Online Resources - Online (22) 22
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Markham Stouffville Hospital - Stacks (2) 2
Scarborough Hospital - General (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (2) 2
Bridgepoint Health - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Special Collections (1) 1
Lakeridge Health Sciences - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (52933) 52933
German (804) 804
French (762) 762
Japanese (555) 555
Spanish (450) 450
Russian (213) 213
Chinese (189) 189
Italian (163) 163
Polish (51) 51
Portuguese (47) 47
Danish (41) 41
Swedish (34) 34
Dutch (29) 29
Norwegian (28) 28
Hungarian (26) 26
Czech (23) 23
Hebrew (18) 18
Bulgarian (17) 17
Turkish (17) 17
Romanian (12) 12
Finnish (10) 10
Croatian (6) 6
Serbian (5) 5
Arabic (4) 4
Korean (4) 4
Ukrainian (3) 3
Afrikaans (2) 2
Greek (2) 2
Lithuanian (2) 2
Slovak (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


World Journal of Urology, ISSN 0724-4983, 4/2014, Volume 32, Issue 2, pp. 475 - 479
Our aim was to assess the effect of surgical wait time on the survival of patients with urological neoplasms, including prostate, bladder, penile, and testicular cancers and upper tract tumours (UTUC... 
Nephrology | Medicine & Public Health | Urology/Andrology | Renal cell carcinoma | Surgery | Oncology | Urothelial carcinoma | Waiting time | Survival | Prostate cancer | BLADDER-CANCER | SMALL RENAL MASSES | MANAGEMENT | RADICAL PROSTATECTOMY | SURVEILLANCE | UROLOGY & NEPHROLOGY | CYSTECTOMY | QUALITY-OF-LIFE | DELAY | Carcinoma, Transitional Cell - mortality | Penile Neoplasms - diagnosis | Prostatectomy - methods | Testicular Neoplasms - mortality | Urologic Neoplasms - diagnosis | Urinary Bladder Neoplasms - diagnosis | Humans | Carcinoma, Renal Cell - surgery | Male | Prostatic Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - diagnosis | Nephrectomy - methods | Kidney Neoplasms - diagnosis | Testicular Neoplasms - surgery | Kidney Neoplasms - surgery | Time Factors | Neoplasms, Germ Cell and Embryonal - mortality | Penile Neoplasms - mortality | Testicular Neoplasms - diagnosis | Urinary Bladder Neoplasms - mortality | Prostatic Neoplasms - surgery | Time-to-Treatment | Urologic Neoplasms - mortality | Carcinoma, Transitional Cell - diagnosis | Kidney Neoplasms - mortality | Urinary Bladder Neoplasms - surgery | Prostatic Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Penile Neoplasms - surgery | Carcinoma, Renal Cell - diagnosis | Ureteral Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - surgery | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Cystectomy - methods | Orchiectomy - methods | Urologic Neoplasms - surgery | Diagnosis | Health aspects | Tumors
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
Japanese journal of clinical oncology, ISSN 1465-3621, 2016, Volume 46, Issue 6, pp. 497 - 501
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 2, pp. 720 - 726
Purpose To analyze the effect of reduced-dose radiotherapy on local control in children with low-risk rhabdomyosarcoma (RMS) treated in the Children’s Oncology... 
Radiology | Hematology, Oncology and Palliative Medicine | Radiotherapy | Local control | Low risk | Rhabdomyosarcoma | PARAMENINGEAL RHABDOMYOSARCOMA | INTERNATIONAL SOCIETY | INTERGROUP-RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | SURGICAL-MANAGEMENT | FAILURE | RADIATION-THERAPY | STUDY-IV | GROUP-III PATIENTS | ONCOLOGY | PATIENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lymph Node Excision | Prostatic Neoplasms - radiotherapy | Age Factors | Humans | Child, Preschool | Infant | Male | Rhabdomyosarcoma, Embryonal - surgery | Neoplasm, Residual | Young Adult | Rhabdomyosarcoma, Embryonal - secondary | Treatment Failure | Adult | Female | Urogenital Neoplasms - drug therapy | Orbital Neoplasms - surgery | Child | Infant, Newborn | Orbital Neoplasms - radiotherapy | Prostatic Neoplasms - drug therapy | Rhabdomyosarcoma, Embryonal - pathology | Quality Control | Prostatic Neoplasms - pathology | Drug Administration Schedule | Prostatic Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Orbital Neoplasms - pathology | Urogenital Neoplasms - pathology | Orbital Neoplasms - drug therapy | Lymphatic Metastasis | Rhabdomyosarcoma, Embryonal - drug therapy | Tumor Burden | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Radiotherapy Dosage - standards | Urogenital Neoplasms - radiotherapy | Adolescent | Combined Modality Therapy - methods | Urogenital Neoplasms - surgery | Rhabdomyosarcoma, Embryonal - radiotherapy | Second-Look Surgery | Head and Neck Neoplasms - surgery | SURGERY | PATIENTS | NEOPLASMS | LYMPH NODES | FAILURES | RADIOLOGY AND NUCLEAR MEDICINE | ENDOXAN | RADIATION DOSES | RADIOTHERAPY | CHILDREN | CONTROL | HAZARDS | Low-risk | Local Control
Journal Article
CardioVascular and Interventional Radiology, ISSN 0174-1551, 10/2013, Volume 36, Issue 5, pp. 1190 - 1203
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 69, Issue 1, pp. 9 - 12
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 2016, Volume 42, Issue 12, pp. 1787 - 1797
Journal Article
Clinical Lung Cancer, ISSN 1525-7304, 2017, Volume 18, Issue 5, pp. 543 - 550.e3
... exposure (≥20 pack-years) . The National Comprehensive Cancer Network (NCCN) and the American Association for Thoracic Surgery (AATS) have reduced the age and pack... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | NSCLC | Survivor | Radiation | Screening criteria | Smoking | SURGERY | HODGKINS LYMPHOMA SURVIVORS | RADIATION-THERAPY | HORMONE USE | BREAST-CANCER | WOMEN | ONCOLOGY | RADIOTHERAPY | CARCINOMA | HISTORY | Melanoma - epidemiology | Smoking - adverse effects | Lung Neoplasms - ethnology | United States - epidemiology | Prostatic Neoplasms - radiotherapy | Kidney Neoplasms - epidemiology | Pancreatic Neoplasms - epidemiology | Neoplasms, Second Primary - ethnology | Humans | Middle Aged | Thyroid Neoplasms - epidemiology | Uterine Neoplasms - epidemiology | Colorectal Neoplasms - radiotherapy | Male | Hematologic Neoplasms - epidemiology | Incidence | Hematologic Neoplasms - radiotherapy | Head and Neck Neoplasms - epidemiology | Female | Uterine Neoplasms - radiotherapy | Urinary Bladder Neoplasms - epidemiology | Adenocarcinoma - radiotherapy | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | SEER Program | Risk Factors | Melanoma - radiotherapy | Carcinoma, Non-Small-Cell Lung - epidemiology | Pancreatic Neoplasms - radiotherapy | Carcinoma, Non-Small-Cell Lung - ethnology | Thyroid Neoplasms - radiotherapy | Kidney Neoplasms - radiotherapy | Neoplasms, Second Primary - epidemiology | Prostatic Neoplasms - epidemiology | Head and Neck Neoplasms - radiotherapy | Breast Neoplasms - radiotherapy | Urinary Bladder Neoplasms - radiotherapy | Lung Neoplasms - epidemiology | Smoking - epidemiology | Sex Factors | Aged | Adenocarcinoma - epidemiology | screening criteria | radiation | smoking | survivor
Journal Article
Nature cell biology, ISSN 1476-4679, 2018, Volume 20, Issue 8, pp. 954 - 965
... of Cambridge, Cambridge, UK. 2Academic Urology Group, Department of Surgery, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge, UK... 
PATHWAY CHOICE | STRAND BREAK REPAIR | RESECTION | DAMAGE-RESPONSE | 53BP1 | CLASS-SWITCH RECOMBINATION | FANCONI-ANEMIA | DIFFERENTIAL EXPRESSION ANALYSIS | POLYMERASE-ZETA | TELOMERES | CELL BIOLOGY | Osteosarcoma - drug therapy | Mad2 Proteins - metabolism | Humans | Multiprotein Complexes | Ovarian Neoplasms - pathology | Bone Neoplasms - pathology | DNA Breaks, Double-Stranded | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Ovarian Neoplasms - genetics | Telomere-Binding Proteins - genetics | DNA End-Joining Repair | HEK293 Cells | Female | Bone Neoplasms - genetics | Ovarian Neoplasms - metabolism | Bone Neoplasms - drug therapy | BRCA1 Protein - deficiency | Telomere-Binding Proteins - metabolism | Ovarian Neoplasms - drug therapy | Osteosarcoma - metabolism | DNA-Binding Proteins | Tumor Suppressor p53-Binding Protein 1 - metabolism | Recombinational DNA Repair | Tumor Suppressor p53-Binding Protein 1 - genetics | Cisplatin - pharmacology | Breast Neoplasms - drug therapy | Proteins - genetics | Xenograft Model Antitumor Assays | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Proteins - metabolism | Breast Neoplasms - pathology | Mad2 Proteins - genetics | Cell Line, Tumor | Mice | Osteosarcoma - genetics | Cell Cycle Proteins | Osteosarcoma - pathology | Care and treatment | DNA | Cancer cells | Breast cancer | Genetic aspects | Research | Gene expression | Single-stranded DNA | DNA damage | Homologous recombination | Poly(ADP-ribose) | Homology | Genomes | Inactivation | Proteins | Ribose | Null cells | Deoxyribonucleic acid--DNA | BRCA2 protein | CRISPR | Deactivation | BRCA1 protein | Poly(ADP-ribose) polymerase | Adenosine diphosphate | Oligosaccharides | Double-strand break repair | Screens | Cisplatin | Polymerase | Inhibitors | Prostate | Viability | Tumors | Telomere-Binding Proteins / metabolism | Osteosarcoma / genetics | Telomere-Binding Proteins / genetics | BRCA1 Protein / genetics | Cellular Biology | Genetics | Proteins / genetics | Osteosarcoma / drug therapy | Ovarian Neoplasms / genetics | Mad2 Proteins / genetics | Proteins / metabolism | Breast Neoplasms / drug therapy | Breast Neoplasms / metabolism | Tumor Suppressor p53-Binding Protein 1 / genetics | BRCA1 Protein / deficiency | Ovarian Neoplasms / metabolism | Mad2 Proteins / metabolism | Breast Neoplasms / pathology | Bone Neoplasms / genetics | Ovarian Neoplasms / pathology | Bone Neoplasms / pathology | Life Sciences | Bone Neoplasms / drug therapy | Ovarian Neoplasms / drug therapy | Osteosarcoma / metabolism | Biochemistry, Molecular Biology | Breast Neoplasms / genetics | Drug Resistance, Neoplasm / genetics | Osteosarcoma / pathology | Bone Neoplasms / metabolism | Poly(ADP-ribose) Polymerase Inhibitors / pharmacology | Cisplatin / pharmacology | Molecular biology | Tumor Suppressor p53-Binding Protein 1 / metabolism | Cancer
Journal Article
The prostate journal, ISSN 1095-5100, 1999
Journal
Journal Article